TrialBreast (Edinburgh, Scotland)2013

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial.

Diana Crivellari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.